Study to Investigate the Absolute Bioavailability of a Single Oral Dose of Ponesimod in Healthy Male Subjects
NCT02068235
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
17
Enrollment
INDUSTRY
Sponsor class
Conditions
Healthy
Interventions
DRUG:
Ponesimod 5mg i.v.
DRUG:
Ponesimod i.v.
DRUG:
Ponesimod 10 mg tablet
Sponsor
Actelion